Views & Analysis The promising future of RNA RNA technology-based therapeutics are a new and novel way to treat diseases.
News WuXi to build new $60m clinical and manufacturing plant WuXi Biologics has pledged to invest $60 million into a new US-based site to expand its clinical and manufacturing arm.
News Cavanaugh to replace Taubert as J&J's pharma head Jennifer Taubert will hand over the reins of Johnson & Johnson's Innovative Medicines division to Tom Cavanaugh after she retires on 1st September.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
